The Patent Finder

Shenzhen TargetRx, Inc.

37 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Dec 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Benzenesulfonylbenazamide compound for inhibiting BCL-2 protein and composition and use thereof (US 11,718,611) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity (US 11,746,110) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Substituted Pyrazole Compounds, Compositions Containing Same, and Use Thereof (US 11,802,113) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 1 fee due May 19, 2027
    The maintenance fee for Substituted heteroaryl compound, composition containing same, and application thereof (US 10,479,767) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
  • 2 fees due Jun 12 to 30, 2027 · next Jun 12
  • 1 fee due Jul 28, 2027
    The maintenance fee for Macrocycle and Composition Comprising Thereof (US 10,543,199) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,479,767Substituted heteroaryl compound, composition containing same, and application thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,851,062Substituted heteroaryl compound, composition containing same, and application thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,519,193Steroidal compound, composition containing the same and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,543,199Macrocycle and Composition Comprising Thereof
In force
 · High confidence
In forceHigh confidence
US 10,780,082Macrocycle and Composition Comprising Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,995,103Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,111,233Amino pyrimidine compound for inhibiting protein tyrosine kinase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,517,561Macrocycle and Composition Comprising Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,875,853(Hetero)arylamide compound for inhibiting protein kinase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,091,462(Hetero)arylamide compound for inhibiting protein kinase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited